Medical News

RSS

Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to anthracyclines

Cell Therapeutics, Inc. announced today an abstract to be published online at the journal Blood website by M. Hacker, et al. demonstrating significant reduction in cardiac cell toxicity with pixantrone compared to currently marketed anthracyclines. The authors conclude that the reduction is due to pixantrone's inability to generate toxic drug iron complexes and reduced propensity to generate oxygen free radicals.

8 Dec 2009

$Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma$

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Onyx Pharmaceuticals, Inc. today announced results from an ongoing Phase 2 study, known as the 004 study, of the company's lead proteasome inhibitor, carfilzomib.

8 Dec 2009

Documentary presents inspirational story of kids with autism and Asperger's syndrome

Millions of people around the world are achieving success every day, but no accomplishments are as impressive as those achieved by people for whom everyday life is a challenge. "Kids With Cameras," a documentary presented by Polaris Media Group, to be released on December 15th, is a heartwarming and inspirational story of many such accomplishments achieved by kids with autism and Asperger's syndrome.

8 Dec 2009

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology’s annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

8 Dec 2009

Tips for avoiding holiday weight gain

With obesity rates at all time highs, and the season of food, comfort and overindulgence right around the corner, the fear of weight gain is very real for most people. Keep off those pesky holiday pounds by upping fitness this December, and get a jump start on that New Year's resolution with the help of some guidance from Life123.com, a leading source of expert advice.

8 Dec 2009

AbSorber receives patent protection for its XM-ONE in the European countries

AbSorber has received patent protection for its transplantation cross match-test XM-ONE® in the European countries. The patent was previously approved in New Zealand which was the first country to approve a patent for AbSorbers product.

8 Dec 2009

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

Sickle cell disease, a condition characterized by deformed and dysfunctional red blood cells, is one of the most common genetic blood disorders affecting millions of people around the world, including more than 70,000 Americans (National Heart, Lung, and Blood Institute.

8 Dec 2009

ISST researchers develop software for physicians to have weekly 'Wound Conference'

Wounds suffered by patients with diabetes tend to heal poorly. For treatment to work, the patient's physician must discuss the situation with specialists and nursing staff to decide on the best approach. However, e-mailing the files containing the diagnosis and discussing them on the telephone is a time-consuming process.

8 Dec 2009

Department of Health reminds at-risk Pennsylvanians to receive H1N1 vaccination

The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 2,940,300 doses of H1N1 flu vaccine to Pennsylvania to date, the state Department of Health said today.

8 Dec 2009

Erbitux gaining market share of Avastin in Europe

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite its dominance in early lines of metastatic colorectal cancer treatment, Roche/Chugai's Avastin will face increasing competition from Bristol-Myers Squibb/Eli Lilly/Merck KGaA's Erbitux in Germany, France and Spain.

8 Dec 2009

TAFP and RemitDATA team up to improve revenue and reimbursement trends

RemitDATA, Inc., a leading provider of web-based productivity tools and benchmarking to the outpatient healthcare market, today announced that Texas Academy of Family Physicians (TAFP), the largest medical specialty organization, serving over 5,500 family physicians in Texas, has joined forces with RemitDATA to aggregate members' reimbursement data and provide real-time payer benchmarking to help TAFP identify problematic payers and troubling reimbursement trends before they turn into cash-flow pitfalls.

8 Dec 2009

Muscle Flex returns to 'Current Information' status with PinkSheets.com

Muscle Flex Inc. (www.MuscleFlex.com) announced today that it has returned to 'Current Information' status with PinkSheets.com after filing its required financial information.

8 Dec 2009

Tranzyme Pharma and Bristol-Myers Squibb sign collaboration agreement

Tranzyme Pharma today announced that it has entered into a strategic collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds directed against targets of interest to Bristol-Myers Squibb.

8 Dec 2009

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

8 Dec 2009

VisionShare to enable connectivity to the NHIN and HIEs from its secure exchange platform

VisionShare, one of the nation’s largest and most secure health information exchanges for administrative transactions, today announced plans to expand support for the exchange of clinical transactions on its platform and making connectivity to the Nationwide Health Information Network (NHIN) and state and community-based Health Information Exchanges (HIEs) available to its customers.

8 Dec 2009

Catholics for Choice's statement on restriction of abortion coverage

"Today, Senator Ben Nelson (D-Nebraska) put the policy priorities of the U.S. Catholic bishops before the needs of women nationwide. Originally, Senator Nelson maintained that the abortion language in the healthcare bill was not a make-or-break factor in his vote.

8 Dec 2009

West Nile Virus can become more widespread in Europe than previously thought, says new report

Potentially fatal mosquito-borne West Nile fever (WNF) can become much more widespread in Europe than previously thought, say scientists in a new report just out in the journal BMC Evolutionary Biology(1).

8 Dec 2009

Opportunity for wireless technologies in Western Europe's e-healthcare market

Healthcare in Europe is facing major challenges in both structural reform and unavailability of resources as the region's working population is far lower in comparison to those of 'non-working' age. This calls for the introduction of new schemes in healthcare that would enable Europe to deal with issues pertaining to the growing ageing population.

8 Dec 2009

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.

8 Dec 2009

CML patients on nilotinib or dasatinib drug achieve better response than imatinib drug

Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.

8 Dec 2009

Medical News

Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to anthracyclines

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Documentary presents inspirational story of kids with autism and Asperger's syndrome

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Tips for avoiding holiday weight gain

AbSorber receives patent protection for its XM-ONE in the European countries

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

ISST researchers develop software for physicians to have weekly 'Wound Conference'

Department of Health reminds at-risk Pennsylvanians to receive H1N1 vaccination

Erbitux gaining market share of Avastin in Europe

TAFP and RemitDATA team up to improve revenue and reimbursement trends

Muscle Flex returns to 'Current Information' status with PinkSheets.com

Tranzyme Pharma and Bristol-Myers Squibb sign collaboration agreement

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

VisionShare to enable connectivity to the NHIN and HIEs from its secure exchange platform

Catholics for Choice's statement on restriction of abortion coverage

West Nile Virus can become more widespread in Europe than previously thought, says new report

Opportunity for wireless technologies in Western Europe's e-healthcare market

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

CML patients on nilotinib or dasatinib drug achieve better response than imatinib drug

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News